Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Fellowship Programme supporting Career Development and Interdisciplinary Training in Omics driven Personalised Medicine (TOPMed10)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Co-funding of regional, national and international programmes (COFUND)-Fellowship programmes
Action type: Marie Skłodowska-Curie actions
Countries involved: Germany,Ireland,Ireland,Netherlands,United Kingdom
Call: Marie Skłodowska-Curie Co-funding of regional, national and international programmes (COFUND-FP) (H2020-MSCA-COFUND-2014, 2014)
Start date: 2015-07-01
End date: 2021-06-30
Duration (months): 72.0
Total project cost (EUR): 1770000.0
EU funding (EUR): 885000.0
Participants: 7
Project status: CLOSED

UCD proposes the implementation of a new postdoctoral fellowship programme supporting career development and interdisciplinary training in omics driven Personalised Medicine for 10 high calibre experienced researchers undertaking transnational ‘incoming’ mobility to Ireland (TOPMed10). Experienced researchers, by definition under Marie Sklodowska-Curie Actions (MSCA), are those in possession of a doctoral degree (or at least 4 years of research experience (FTE)) at the time of the deadline for the submission of their fellowship proposal. TOPMed10 offers 10 prestigious fellowships, 2-3 years in duration, across two calls. Fellowships will be offered at 2 levels: level 1 will be targeted at incoming experienced researchers (as per MSCA definition) with 0-3 years additional research experience and level 2 will be targeted at incoming experienced researchers (as per MSCA definition) with 3+ years additional research experience. Career breaks will be taken into account. Fellowships of level 1 and 2 are open to candidates of any nationality who, at the time of the deadline for submission of proposals, shall not have resided or carried out their main activity (work, studies, etc.) in Ireland for more than 12 months in the 3 years immediately prior to the deadline for submission date. Compulsory national service and/or short stays such as holidays are not taken into account. Fellowships will be based in the UCD Research Institutes (Systems Biology Ireland, UCD Charles Institute of Dermatology, UCD Conway Institute of Biomolecular and Biomedical Research and the UCD Clinical Research Centre). Fellows may undertake an optional 3-9 month secondment to a Partner Organisation (incl. academic, industry, clinical sector) or a research performing organisation in any country in the world deemed to be appropriate in terms of meeting the needs of the fellows’ research, training and career development requirements.

Keywords: personalised medicine,omics,translational biology,computational modelling,molecular bioinformatics,clinical informatics,biostatistics,career development,interdisciplinary training
Optical Manipulation of Colloidal Interfaces, Droplets and Crystallites (OMCIDC)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Consolidator grants
Action type: ERC actions
Panel: Condensed matter physics
Panel description: Structure, electronic properties, fluids, nanosciences, biological physics
Countries involved: Netherlands,United Kingdom
Call: ERC Consolidator Grant (ERC-2016-COG, 2016)
Start date: 2017-06-01
End date: 2023-09-30
Duration (months): 76.0
Total project cost (EUR): 1999892.0
EU funding (EUR): 480405.41
Participants: 2
Project status: SIGNED

This multidisciplinary research programme is focussed on the optical manipulation of interfaces, droplets and crystallites in colloidal model systems. In particular, we will use holographic optical tweezing and confocal microscopy to study interfacial phenomena in three different phase separated colloid-polymer mixtures, exhibiting colloidal liquid-gas, crystal-gas and nematic-isotropic phase coexistence, respectively. First, we will determine the full potential energy landscape of the optical traps using the relation between interface fluctuations and deformed liquid-gas interfaces. This will then be used to study the complex and anisotropic interfacial properties of crystal-gas and nematic-isotropic interfaces. In addition, we envisage quantitatively investigating the nucleation of colloidal liquid droplets, crystallites and liquid crystalline droplets in optical traps positioned at well-defined heights above the interface, which is a direct and quantitative measure for the undersaturation. This allows us to systematically study the relation between the quench depth, nucleus size and nucleation times. We will furthermore nucleate multiple droplets, crystallites and liquid crystalline droplets to study their optical trapping controlled coalescence and detachment, which will shed completely new light on for instance the single particle structure and dynamics upon coalescence and detachment. Finally, we will introduce large probe particles into the phase separated colloid-polymer mixtures, which enables the study of important phenomena such as heterogeneous nucleation and capillary condensation, crystallisation and nematisation. This ambitious project opens up a huge range of exciting possibilities to gain a deep and fundamental understanding of interfacial phenomena in complex fluids by actively manipulating and controlling colloidal interfaces, droplets and crystallites.

Keywords: colloids,optical tweezing,confocal microscopy
FUND raising acCELERATOR for long time-to-market path SMEs (FUNDCELERATOR)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: Coordination and support actions
Countries involved: Spain,Ireland,Germany,France
Call: peer learning of innovation agencies (H2020-INNOSUP-2014-5, 2014)
Start date: 2016-04-01
End date: 2017-03-31
Duration (months): 12.0
Total project cost (EUR): 50000.0
EU funding (EUR): 50000.0
Participants: 5
Project status: CLOSED

The FUNDCELERATOR project will aim at developing a new fund raising support methodology targeting innovative and high-growth potential SMEs operating in markets characterized by long time-to-market paths (typically more than 3 years, such as in biotech, medical devices, materials, cleantech, aeronautics, etc.). Based on their respective experience, knowledge and already developed fund raising support tools and methodologies, the 4 involved innovation support organizations will make use of the “Twinning advanced” methodological approach to collaboratively build and test an improved fund raising acceleration support programme dedicated to the target group SMEs, relying also, in a systemic mode, on all the existing fund raising support services provided by other regional private or public stakeholders. As part of the project, the regional innovation support agency from Aquitaine (ADI, France), the Baden-Württemberg regional innovation and business support organization (BWCON, Germany), the Dublin Business & Innovation Centre (DUBLIN BIC, Ireland) and the regional business and innovation incubator from Murcia (CEEIM, Spain) will experiment the new enhanced fund raising support methodology and evaluate its performance and impacts on beneficiaries (adequacy to their needs, service quality and efficiency) while beginning to apply and to test the new approach with 8 to 10 SMEs (at least 2 per partner). As a result, the new improved fund raising support methodology will be documented in a Design Option Paper (DOP), as a guide to be disseminated into other innovation support organisations, helping them at implementing the new designed programme, providing them recommendations, returns on experience and performance results.

Keywords: fund raising
Smart tomographic sensors for advanced industrial process control (TOMOCON)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Innovative Training Networks (ITN)-European Training Networks
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: Germany,Germany,Austria,Germany,Finland,Finland,Poland,Sweden,Switzerland,Finland,France,France,Czechia,Netherlands,Netherlands,United Kingdom,Brazil
Call: Innovative Training Networks (H2020-MSCA-ITN-2017, 2017)
Start date: 2017-09-01
End date: 2022-02-28
Duration (months): 54.0
Total project cost (EUR): 3819642.12
EU funding (EUR): 3819642.12
Participants: 27
Project status: CLOSED

A decisive gap in the process industry is the lack of qualified distributed process parameter measurements for optimal control. Process tomography is a ground-breaking technology to bridge this gap. Just with the recent development in high-power massive parallel computing this technology has gained the required real-time capability. TOMOCON as a European network of leading academic and industrial partners from different sectors dedicates its efforts in research and training towards development of tomography-based industrial process control. With that it shall generate new scientific and technical knowledge in this emerging field; develop and demonstrate new technological solutions of advanced industrial control by tomographic sensors; align tomography-based process control with concepts of knowledge-based control, big data analysis and advanced human-machine interfaces; and enhance the scientific and transferable skills of early stage researchers to meet future needs of the industry. Together with world-leading industrial sensor and control solution providers, process engineering and production companies TOMOCON shall demonstrate the functionality of tomography-assisted process control in four industry-relevant demonstration cases, which serve as benchmarks to demonstrate improvements in energy and resource efficiency as well as product quality. That is: control of inline fluid separation, control of microwave drying processes, control of continuous metal casting, and control of batch crystallization processes.

Keywords: process tomography,process control,process modelling,massive parallel computing,sensor technology,control theory,human machine interfaces,process design,inline fluid separation,microwave tech
Maltese-European Linkages for Internationalisation, Innovation and Technology Transfer [3] (MELIITA 3 H2020)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: Specific Grant agreement
Countries involved: Malta
Call: EEN H2020 SGA3 (H2020-EEN-SGA3-2018, 2018)
Start date: 2019-01-01
End date: 2019-12-31
Duration (months): 12.0
Total project cost (EUR): 16176.25
EU funding (EUR): 16176.25
Participants: 4
Project status: CLOSED

The objective behind the MELIITA 3 proposal is to support the smart growth of Maltese SMEs by increasing the efficiency and effectiveness of investments in research, development and innovation and to contribute to a better and more efficient connection of stakeholders and players along the innovation chain. By combining the actions under this Horizon2020 programme with the support being offered under COSME, the Network will be best positioned to offer both business and innovation support along the entire value chain. Services are thus being provided to clients in the wider context of, and in line with, the Europe 2020 strategy. There are two specific objectives which the Malta consortium will aim to achieve by end 2019, namely: ● To ensure that key SME beneficiaries of the Horizon2020 programme are supported efficiently and effectively so that their full potential can be exploited; and ● To ensure that the innovation management capacity of Maltese micro and SME clients is enhanced. In order to achieve the first objective, the consortium will commit to assisting beneficiaries of funding schemes like SME Instrument, Fast Track to Innovation, and Future and Emerging Technologies Open through Key Account Management [KAM] services. Specialised Network personnel will be deployed to facilitate coaching services to such clients following the assessment of coaching needs and identification of suitable coaches. The second main objective will be attained through the deployment of Network services to assess the innovation management capacity of pre-identified clients. The activity under this work package is planned to help SMEs become aware of, and address, the main deficiencies in their innovation management systems since this is perceived as a potential barrier to the creation of economic impact from innovation activities.

Keywords: sme instrument,horizon2020,innovation management,smes
ReAlising DynamIc vAlue chaiNs for underuTilised crops (RADIANT)

Framework: Horizon 2020 — Societal Challenges
Programme: Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy
Theme: Sustainable agriculture and forestry
Action type: Research and Innovation actions
Countries involved: Spain,Ireland,Ireland,Ireland,Italy,Italy,Italy,Italy,Germany,Germany,Spain,Italy,Germany,Italy,Cyprus,Greece,Greece,Slovenia,Slovenia,Bulgaria,Belgium,Hungary,Netherlands,United Kingdom,Portugal,United Kingdom,Portugal,Portugal,United Kingdom
Call: Biodiversity in action: across farmland and the value chain (H2020-SFS-2020-2, 2020)
Start date: 2021-09-01
End date: 2025-08-31
Duration (months): 48.0
Total project cost (EUR): 5999715.0
EU funding (EUR): 5999715.0
Participants: 31
Project status: SIGNED

RADIANT implements a suite of strategic and fully inclusive multi-actor engagement methods to co-develop solutions and tools to ensure that agrobiodiversity in the form of underutilised crops (UCs) is realised via Dynamic Value Chains (DVCs). RADIANT characterises DVCs as ’a system-state where open information sharing among all value-chain actors allows resilient adaptation to disruptions and sustainable economic development’. RADIANT adopts a ‘Theory of Change’ approach, where desired system-level states, such as crop diversification, environmental and agrobiodiversity preservation, and fair economic development are monitored and mapped to identify and implement the necessary transformation avenues. RADIANT’s 28 multi-actor consortium is composed of highly skilled value chain actors, researchers, and end-users. The scientific excellence of the work plan will release the value of UCs and enable a transformation towards sustainable DVCs that foster agrobiodiversity in educational, financial, technological settings and effectively provisions UCs to farmers’ fields and consumers’ tables. This will be achieved via eight complementary work packages to: identify, collect, and multiply the genetic resources of core UCs for breeding and farming; widen UC recognition by capturing their ecosystem services; enhance their processing by co-creating novel food and non-food products; invite stakeholders and aspiring participatory farmers into a capacity-building, mentoring-network to trial, test, and embed UCs in sustainable DVCs; co-creating Apps and ‘UC-Transition Diaries’ to record their transformation; and engage stakeholders to co-design policy instruments, and deliver a decision support tool to create sustainable avenues for DVCs. In sum, the RADIANT approach will empower value chain and policy actors to reach out to 1 million farmers and more than 60 million potential consumers to promote the uptake of UCs in farming, processing, manufacturing, and retailing practices.

Keywords: underutilised crops,dynamic value chains,farmers,consumers,value chain actors,decision support systems,co creation,sustainability,resilience,legumes
European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry (EN_ACTI2NG)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Innovative Training Networks (ITN)-European Training Networks
Action type: Marie Skłodowska-Curie actions
Panel: Life Sciences
Countries involved: Austria,Germany,Germany,Germany,Germany,Austria,Spain,Spain,Spain,Netherlands,United Kingdom,United Kingdom
Call: Innovative Training Networks (H2020-MSCA-ITN-2016, 2016)
Start date: 2017-01-01
End date: 2021-04-30
Duration (months): 52.0
Total project cost (EUR): 2539859.76
EU funding (EUR): 2539859.76
Participants: 14
Project status: CLOSED

The EN-ACTI2NG program (European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry) emanates from the recent clinical evidence that T cells expressing engineered tumor-specific immune receptors can eradicate certain tumors that do not respond to conventional treatment. To obtain T cells with reactivity to a wider array of tumors and to improve efficiency and on- and off-target toxicity are current challenges Therefore the EN-ACTI2NG program aims 1) to train PhD students with expertise in development of new and improved T cell-mediated cancer immuno-therapies; 2) to endow the PhD students with the ability to establish efficient communication between the academic and industrial research environments and between scientists and the general public; 3) to improve T cell mediated anti-cancer immuno-therapy by the identification and development of new cancer-specific immune receptors and enhancing their function by identifying and modifying their molecular mechanism of action. To reach these objectives we have designed individual research projects ranging from biophysical analysis of immune receptors, via molecular modification of their structure and testing their tumor killing capacity in cell-based and pre-clinical assays to product development. Secondments will assure that each PhD student will be exposed to these complementary approaches and that there will be synergic feedback between the projects, producing innovative results that could otherwise not be achieved. Extensive training in research-specific skills, career development and a continuous training in communication skills will allow the PhD students to become facilitators of the process of transformation of scientific innovation into products with social and economic value. As such, the EN-ACTI2NG program should contribute to overcoming the more general challenge of converting the European Community into an innovation-driven society.

Keywords: chimeric antigen receptors,t cell receptor,tumor specific t cells,translational immunology,biochemistry of signaling,receptor clustering,super resolution fluorescence microscopy
“Rehabilitation: Family Role within the UK in comparison to Turkey” (RE-FRUIT)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: United Kingdom
Call: Marie Skłodowska-Curie Individual Fellowships (IF-EF) (H2020-MSCA-IF-2015, 2015)
Start date: 2016-08-01
End date: 2017-08-31
Duration (months): 13.0
Total project cost (EUR): 99371.35
EU funding (EUR): 99371.35
Participants: 1
Project status: CLOSED

This fellowship will grow the participant's skills and experience in social aspects of rehabilitation. The research project aims to analyse the role of the family in in-patient and out-patient rehabilitation for disabled people in the UK and compare it with evidence previously gathered in Turkey. More widely, the sociology of rehabilitation is underdeveloped in disability research. Rehabilitation sciences have neglected the social and cultural dimensions of their work; conversely, disability studies has neglected the domain of rehabilitation. However rehabilitation is a key turning point in the lives of many disabled people. The role of the family is also of special importance, given the emphasis on independent living. This is especially so today, when neoliberal and austerity policies in the UK mean that state services are contracting and there is likely to be an expanding role for informal care and family support. The project will examine the role that families play in rehabilitation, the experiences of disabled people with such family involvement, and the situation for people who lack available family support, and compare the case of UK with the Turkish example. The project is designed as a qualitative case study, employing a variety of data collection strategies such as the use of participant observation, semi-structured interviews, focus groups, secondary sources, and the method of comparative analysis. This is an interdisciplinary project strengthened by the disciplines of sociology, philosophy, political science, and rehabilitation sciences, with the potential to make significant contributions to the fields of sociology of rehabilitation, disability studies and public policy. As well as the training dimension of the research (project management, focus group research, disability studies), the fellowship will also generate a research network proposal on post-conflict rehabilitation and integration research (enhancing European project writing skills).

Keywords: rehabilitation,disability,family s role
VACCELERATE - European Corona Vaccine Trial Accelerator Platform (VACCELERATE)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Treating and managing disease
Action type: Research and Innovation actions
Countries involved: Spain,Austria,Ireland,Ireland,Italy,Israel,Germany,Spain,Spain,Germany,Cyprus,Switzerland,Norway,Serbia,Türkiye,Belgium,Poland,Sweden,Lithuania,Norway,Greece,Hungary,Slovakia,France,Czechia,Netherlands,Denmark,Portugal
Call: EU-wide Covid-19 vaccine trial network (H2020-IBA-SC1-CORONAVIRUS-2020-4, 2020)
Start date: 2021-01-28
End date: 2024-01-27
Duration (months): 36.0
Total project cost (EUR): 26499804.49
EU funding (EUR): 26499804.49
Participants: 36
Project status: SIGNED

The ongoing COVID-19 pandemic creates an unprecedented burden worldwide. Vaccine-induced immunity is the only promising solution. There is continued need for phase 2 & 3 vaccine trials to reach long-term, large-scale immunity of the entire European population. VACCELERATE will be the pan-European backbone accelerating phase 2 & 3 COVID-19 vaccine trials. The overall objective of VACCELERATE is to connect all European stakeholders involved in vaccine development to provide a pan-European platform for clinical trial design and conduct. VACCELERATE constitutes the rapid response single entry-point to stakeholders from public health authorities to vaccine developers, to address respective needs and kick-start specifically phase 2 & 3 vaccine trials. VACCELERATE conducts capacity mapping of clinical trial and laboratory sites to identify suitable sites for individual phase 2 & 3 vaccine trials. Capacity building via training will increase quality in sites across Europe. Volunteer registries facilitate patient recruitment. Access to laboratory sites and a standardised set of assays essential for clinical phase 2 & 3 trials is provided. A harmonised European approach to vaccine trials is enabled by aligning educational standards, coordination of laboratory support and providing standardised assays and trial protocols. Harmonised data collection, open data sharing and pooling of data for stronger analysis enables data standardisation. VACCELERATE offers solutions for characteristic vaccine development issues during pandemics by closing gaps in public health knowledge and improving knowledge transfer. VACCELERATE amalgamates the vast but scattered expertise across Europe into one network to deliver strategic scientific leadership and guidance on vaccine trials in Europe. Beyond the COVID-19 pandemic, it will be an established pandemic preparedness network, ready to face emerging future pandemics, as well as a pivot in Europe?s capacity to develop vaccines.

Keywords: covid 19,sars cov 2,pandemic preparedness,european platform,network,single entry point,clinical vaccine trials,vaccine development,site mapping,capacity building,data standardisation